Functional chocolate that slows down bacteria linked to stomach cancer is created using recycled grape extracts.
Nordic cohort data suggest gastric bypass may raise long-term risk of rare excluded stomach adenocarcinoma and delay ...
Morning Overview on MSN
This stealthy bacteria could trigger millions of cancer cases worldwide
A single bacterium that silently colonizes the stomachs of billions of people could be responsible for roughly 12 million cancer cases among children born in the last decade, according to new ...
Add Yahoo as a preferred source to see more of our stories on Google. Dr. John Gaetano performs a colonoscopy on Mike Lowe, 45, at Northwestern Lake Forest Hospital on April 18. (Stacey Wescott / ...
Colorectal cancer is now the leading cause of cancer death in men and women in the USA under the age of 50 combined, according to the American Cancer Society.
Chilean chocolate with grape residue slows down bacteria associated with gastric cancer, according to a recent scientific study.
Gastrointestinal stromal tumours (GISTs) are rare stomach tumours driven by KIT or PDGFRA gene mutations. Unlike typical ...
Doctors are increasingly detecting stomach tumors at an early stage, raising hopes for lifesaving treatment for one of the deadliest types of cancer. Stomach cancer, the disease that killed country ...
In response to the alarming rise in digestive cancers among young adults, doctors, researchers, patients, and European policymakers are urging Europe to rethink its strategies for screening, treatment ...
What Are the Treatment Options for Gastrointestinal Cancer? Your treatment plan will depend on several factors including the type of cancer, its stage, your overall health and personal preferences. An ...
Early-onset gastrointestinal (GI) cancers are climbing among those younger than 50 years, in the US and globally. Although colorectal cancer accounts for approximately half of such cases, rates are ...
News-Medical.Net on MSN
Distinct gut toxicity patterns emerge with targeted cancer treatments
A new paper was published in Volume 13 of Oncoscience on February 6, 2026, titled "Gastrointestinal toxicity of targeted cancer therapies in the United States: Clinicopathologic patterns, FDA safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results